Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exozymes (EXOZ) Operating Expenses (2023 - 2024)

Exozymes (EXOZ) has disclosed Operating Expenses for 2 consecutive years, with $2.0 million as the latest value for Q4 2024.

  • Quarterly Operating Expenses rose 101.49% to $2.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2024, changed N/A year-over-year, with the annual reading at $9.7 million for FY2025, 63.79% up from the prior year.
  • Operating Expenses for Q4 2024 was $2.0 million at Exozymes, up from $1.6 million in the prior quarter.
  • The five-year high for Operating Expenses was $2.0 million in Q4 2024, with the low at $391846.0 in Q3 2023.